France TV: You don’t choose to be fat

france tv Enquête de santé - On ne choisit pas d'être gros

A France TV investigation has set the record straight on obesity, debunking the stubborn misconception that it’s merely a lack of willpower. The documentary highlights concrete biological and social factors that explain why we are not all equal in the face of this disease.

Mounjaro (Tirzepatide): The New Revolutionary Treatment for Diabetes and Weight Loss in 2025

Mounjaro, with its active ingredient tirzepatide, marks a significant advancement in treating type 2 diabetes and obesity. This revolutionary drug, developed by Eli Lilly, received FDA approval in May 2022 and EMA approval in September 2022.

Ozempic: Complete Guide to the Revolutionary Treatment for Type 2 Diabetes

Ozempic represents a major advance in the treatment of type 2 diabetes. This injectable medication, based on semaglutide, has revolutionized the management of diabetic patients since its approval by the FDA in 2017 and EMA in 2018, establishing itself as an essential therapeutic reference.